首页> 美国卫生研究院文献>AAPS PharmSciTech >Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol
【2h】

Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol

机译:基于Eudragit®E100 /Carbopol®971P组合的基质片剂对水溶性模型药物扑热息痛的控释和改善压实特性的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this work was to investigate the influence of Eudragit®E100 polymer in modifying the release rates and compaction properties of water soluble model drug paracetamol from Carbopol®971P NF polymer matrix tablets prepared by direct compression. The effects of the ratio of the two polymers, the total polymeric content, and the tablets mechanical strength on paracetamol release rates were investigated. Dissolution studies were conducted using USP XX Π rotating paddle apparatus at 50 rpm and 37°C at three different stages (pH 1.2, 4.8, and 6.8). Results showed that the polymers combination improved significantly the compaction properties of paracetamol tablets as evident by the higher crushing strengths (8.3 ± 0.4 Kp) compared to polymer-free tablets (3.4 ± 0.2 Kp) at intermediate compression pressure of 490 MPa. When combined with Carbopol®971P NF, Eudragit®E100 was found to be capable of extending paracetamol release for more than 12 h compared to 1 h for polymers-free tablets. The combined polymers were able to control paracetamol release in a pH independent pattern. The f2 (similarity factor) analysis showed that the ratio between the polymers and the total polymer concentration exhibited significant impact on drug release rates. In conclusion, Eudragit®E100 when combined with Carbopol®971P NF was capable of improving the compaction and sustained release properties of paracetamol. Korsmeyer–Peppas model was found to be the most suitable for fitting drug release data. The polymer combinations can potentially be used to control the release rates of highly water soluble drugs.
机译:这项工作的目的是研究Eudragit®E100聚合物对通过直接压片制备的Carbopol®971P NF聚合物基质片剂中的水溶性模型药物扑热息痛的释放速率和压实特性的影响。研究了两种聚合物的比例,总聚合物含量和片剂机械强度对对乙酰氨基酚释放速率的影响。使用USP XXⅡ旋转桨装置在三个不同阶段(pH 1.2、4.8和6.8)以50 rpm和37°C的温度进行溶出研究。结果表明,与不含聚合物的片剂(3.4±0.2 Kp)在490MPa的中等压缩压力下相比,具有更高的抗压强度(8.3±0.4 Kp)明显证明了聚合物组合物大大改善了对乙酰氨基酚片的压实性能。与Carbopol®971PNF组合使用时,发现Eudragit®E100能够将扑热息痛的释放时间延长12小时以上,而不含聚合物的片剂则可以延长1小时。合并的聚合物能够以不依赖于pH的模式控制扑热息痛的释放。 f2(相似因子)分析表明,聚合物之间的比例和总聚合物浓度对药物释放速率具有显着影响。总之,Eudragit®E100与Carbopol®971PNF结合使用时,能够改善扑热息痛的压实度和缓释性能。发现Korsmeyer-Peppas模型最适合拟合药物释放数据。聚合物组合物可潜在地用于控制高度水溶性药物的释放速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号